Actively Recruiting
Identification of New Prognostic Markers for Breast Cancer.
Led by University Hospital, Grenoble · Updated on 2023-02-28
1500
Participants Needed
1
Research Sites
1200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same approach had already been used and validated in lung tumors, leukemias and lymphomas. The main objective of the present research is to use tumor samples from patients in a retrospective and prospective cohort to test and validate the relevance of these prognostic markers in breast cancer.
CONDITIONS
Official Title
Identification of New Prognostic Markers for Breast Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult female patients with breast cancer
You will not qualify if you...
- Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix
- Subject under guardianship or subject deprived of liberty
- Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.)
- Male patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Anne-Cécile PHILIPPE
Grenoble, France, 38043
Actively Recruiting
Research Team
A
Anne-Cécile PHILIPPE, Dr
CONTACT
E
Emmanuelle JACQUET, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here